Related Experiment Videos
Surveillance in ulcerative colitis: burdens and benefit.
Gut
|March 1, 1988
Summary
Ulcerative colitis (UC) patients require ongoing surveillance, as 5% of those lost to follow-up developed cancer. Even mild UC cases can progress, necessitating regular monitoring for early cancer detection.
Area of Science:
- Gastroenterology
- Oncology
- Public Health
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
- Long-term surveillance is crucial for managing UC patients and detecting complications.
- Previous studies have highlighted the risk of colorectal cancer in UC patients.
Purpose of the Study:
- To determine the incidence and prevalence of ulcerative colitis in a defined health district.
- To assess the risk of colorectal cancer in UC patients, including those lost to follow-up.
- To evaluate the effectiveness and resource implications of a UC surveillance program.
Main Methods:
- A retrospective review of all ulcerative colitis patients in a health district from 1975-1984.
- Analysis of patient data, including diagnoses, follow-up, colonoscopies, and outcomes.
- Contacting patients lost to follow-up to ascertain their clinical status and outcomes.
Main Results:
- The incidence and prevalence of UC were 7.1 and 84 per 100,000 population, respectively.
- Two asymptomatic and five symptomatic colorectal cancers were detected in the study cohort.
- 43% of patients initially diagnosed with mild colitis had substantial disease and two cancers after eight years.
Conclusions:
- Continuous clinical follow-up is essential for all ulcerative colitis patients, regardless of initial disease severity or extent.
- A structured surveillance program is necessary for early detection of colorectal cancer in UC patients.
- The study provides data on the resources required for an effective UC surveillance program.